Home › Drug Product Listings › Aztreonam

Aztreonam

Trade Name: 
Cayston
Manufacturer/Distributor: 
Gilead Sciences
www.gilead.com/ontario
905-363-8008
Classification: 
Antibacterial
ATC Class: 
J01DF01 - Aztreonam
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2009/09/11
Date Marketed in Canada (yyyy/mm/dd): 
2009/11/11
Presentation: 
Powder for inhalation: 75 mg/vial. DIN: 02329840
Comments: 
Has received a notice of compliance with conditions (NOC/C): for treatment of chronic pulmonary Pseudomonas aeruginosa infection in cystic fibrosis patients who are aged 6 years and older. The medication is inhaled over a few minutes and given multiple times per day for 28 days. This is followed by a 28-day period with no inhaled aztreonam.
Back to: 
Drug Product Listings
  • Share this
  • Printer-friendly version
  • PDF version